Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 2
2008 3
2009 3
2011 4
2012 2
2013 1
2015 2
2016 1
2017 4
2018 2
2019 1
2020 2
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Peripheral neuropathy after burn injury.
Tamam Y, Tamam C, Tamam B, Ustundag M, Orak M, Tasdemir N. Tamam Y, et al. Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:107-11. Eur Rev Med Pharmacol Sci. 2013. PMID: 23436672 Free article.
The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
Sen S, Tuncer A, Ozakbas S, Uzunkopru C, Baba C, Demir S, Beckmann Y, Gumus H, Arslan G, Kilic AK, Altintas A, Yuceyar N, Turan OF, Tutuncu M, Terzi M, Acar P, Bunul SD, Balci BP, Bir LS, Koseoglu M, Mungan S, Gunduz T, Dogan IG, Kotan D, Uygunoglu U, Ekmekci O, Demirkiran M, Kamisli O, Kabay SC, Tamam Y, Omerhoca S, Sevim S, Guler S, Kurtuncu M, Efendi H, Karabudak R, Siva A. Sen S, et al. Among authors: tamam y. Mult Scler Relat Disord. 2022 Feb;58:103399. doi: 10.1016/j.msard.2021.103399. Epub 2021 Nov 19. Mult Scler Relat Disord. 2022. PMID: 35216782 Free PMC article.
Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting.
Altunan B, Ünal A, Efendi H, Köseoğlu M, Terzi M, Kotan D, Tamam Y, Boz C, Güler S, Turan ÖF, Altunrende B, Balcı FB, Turgut N, Akçalı A, Yildirim KA, Günal Dİ, Sunter G, Bingöl A. Altunan B, et al. Among authors: tamam y. Mult Scler Relat Disord. 2023 Sep;77:104880. doi: 10.1016/j.msard.2023.104880. Epub 2023 Jul 12. Mult Scler Relat Disord. 2023. PMID: 37459716
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Acar A, Ugur Cevik M, Evliyaoglu O, Uzar E, Tamam Y, Arıkanoglu A, Yucel Y, Varol S, Onder H, Taşdemir N. Acar A, et al. Among authors: tamam y. Acta Neurol Belg. 2012 Sep;112(3):275-80. doi: 10.1007/s13760-012-0059-4. Epub 2012 Mar 27. Acta Neurol Belg. 2012. PMID: 22450709
31 results